EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

April 5, 2021

Study Completion Date

July 8, 2021

Conditions
Tobacco Smoking
Interventions
DRUG

Varenicline

oral varenicline tablets

BEHAVIORAL

Brief smoking cessation counseling

\~10-minute individual counseling at each of 6 clinic visits

Trial Locations (1)

14260

State University of New York at Buffalo, Buffalo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pfizer

INDUSTRY

lead

State University of New York at Buffalo

OTHER

NCT03262662 - EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking | Biotech Hunter | Biotech Hunter